Search results
28 de may. de 2024 · Learn how granulocyte colony stimulating factors (G-CSFs) can reduce the duration and degree of neutropenia caused by cytotoxic chemotherapy for various cancers. Find out the indications, dosing, side effects, and evidence for G-CSFs in adult patients.
12 de jun. de 2024 · This article reviews the causes, evaluation, and management of neutropenia in adults, as well as the differential diagnosis and pathophysiology of specific neutropenia syndromes. It is intended for clinicians caring for adults with isolated neutropenia and offers CME credit.
7 de jun. de 2024 · Primary neutropenia, with decreased production and marrow hypoplasia, can be due to chronic benign neutropenia, cyclical neutropenia, or other congenital and genetic neutropenias. Acquired neutropenia can be secondary to cytotoxic drugs, leukemia, drug reactions, or infections.
Hace 3 días · Neutropenia was defined as an Absolute Neutrophil Count (ANC) of peripheral blood neutrophils below 2 × 109/L. Factors affecting neutropenia in EC patients treated with CRT using Generalized Estimating Equation (GEE), and Logistic regression was used to further analyze the effect of adding radiotherapy to different chemotherapy cycles on neutropenia, so that patients receive optimal adjuvant ...
4 de jun. de 2024 · Neutropenia is a condition of low neutrophil count in the blood, which can increase the risk of infection. Learn about the types, causes, symptoms, diagnosis, and treatment of neutropenia, and how it differs from ANC.
7 de jun. de 2024 · Neutropenia in children refers to a decrease in the ANC (absolute neutrophil count) in the blood, typically below 1500 cells/mm 3, which is further classified as mild (ANC, 1000–1500/mm 3), moderate (ANC, 500–1000/mm 3), severe (ANC < 500/mm 3), and very severe (ANC < 100/mm 3).
14 de jun. de 2024 · Managing Patients With Neutropenic Fever: Challenges in the Treatment of Infections Caused by Gram-Positive Cocci and Gram-Negative Bacilli. Review current treatment guidelines, the changing spectrum of infections and resistance, and the new concepts of risk assessment and outpatient therapy. Authors: Kenneth V.I. Rolston, MD.
